High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$113K
$113,167
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KALV
S
KalVista Pharmaceuticals, Inc.
Sweeny Nicole
• Officer • Chief Commercial Officer
Sell to Cover
2026-02-23
$61,878
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-02-23 | $61,878 | S | Form 4 |
|
KALV
S
KalVista Pharmaceuticals, Inc.
Sweeny Nicole
• Officer • Chief Commercial Officer
Sell to Cover
2025-11-24
$51,289
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2025-11-24 | $51,289 | S | Form 4 |
|
KALV
M
KalVista Pharmaceuticals, Inc.
Sweeny Nicole
• Officer • Chief Commercial Officer
Equity Compensation
2025-11-22
$0
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Equity Compensation
|
2025-11-22 | $0 | M | Form 4 |
|
KALV
M
KalVista Pharmaceuticals, Inc.
Sweeny Nicole
• Officer • Chief Commercial Officer
Equity Compensation
2025-11-21
$0
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Equity Compensation
|
2025-11-21 | $0 | M | Form 4 |